Hepatitis D: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
m (Bot: Removing from Primary care)
 
(47 intermediate revisions by 11 users not shown)
Line 1: Line 1:
{{CMG}}
__NOTOC__
{{About1|Hepatitis D Virus}}


{{EH}}
'''For patient information click [[Hepatitis D(patient information)|here]]'''
{{Hepatitis D}}
{{CMG}}; {{AOEIC}} {{VK}}; {{JS}}; {{JM}}


==Overview==
{{SK}} Hepatitis delta virus; hepatitis D virus; HDV; Delta Hepatitis; HDV infection; Hep D; Hep d
{{DiseaseDisorder infobox | 
==[[Hepatitis D overview|Overview]]==
  Name = Hepatitis D|
  MeshID = D003699
}}
{{Taxobox
| virus_group = v
| genus  = '''''Deltavirus'''''
| species  = '''''Hepatitis delta virus'''''
}}
{{Search infobox}}
'''Hepatitis D''' is a [[disease]] caused by a small circular [[RNA virus]] ('''Hepatitis delta virus''' or '''hepatitis D virus''', '''HDV'''). HDV is considered to be a [[Satellite (biology)|subviral satellite]] because it can propagate only in the presence of another virus, the [[Hepatitis B|hepatitis B virus (HBV)]]. Transmission of HDV can occur either via simultaneous infection with HBV ([[coinfection]]) or via infection of an individual previously infected with HBV ([[superinfection]]). Both superinfection and coinfection with HDV results in more severe complications compared to infection with HBV alone. These complications include a greater likelihood of experiencing liver failure in acute infections and a greater likelihood of developing liver cancer in chronic infections. In combination with hepatitis B virus, hepatitis D has the highest mortality rate of all the hepatitis infections of 20%.
== Genome structure and similarities to viroids ==


The HDV genome exists as a negative sense, single-stranded, closed circular [[RNA]]. Because of a nucleotide sequence that is 70% self-complementary, the HDV genome forms a partially double stranded RNA structure that is described as rod-like. With a genome of approximately 1700 nucleotides, HDV is the smallest "virus" known to infect animals. However, it has been proposed that HDV may have originated from a class of plant viruses called [[viroids]]. Evidence in support of this hypothesis stems from the fact that both HDV and viroids exist as single-stranded, closed circular [[RNA]]s that have rod-like structures. Likewise, both HDV and viroids contain [[RNA]] sequences that can assume catalytically active structures called [[ribozyme]]s. During viral replication, these catalytic [[RNA]]s are required in order to produce unit length copies of the genome from longer [[RNA]] concatamers. Finally, neither HDV nor viroids encode their own polymerase. Instead, replication of HDV and viroids requires a host polymerase that can utilize [[RNA]] as a template. Based on indirect evidence, [[RNA]] polymerase II has been implicated in the replication of HDV. Normally [[RNA]] polymerase II utilizes [[DNA]] as a template and produces [[mRNA]]. Consequently, if HDV indeed utilizes [[RNA]] polymerase II during replication, it would be the only known pathogen capable of converting a [[DNA]] dependent polymerase into an [[RNA]] dependent polymerase.
==[[Hepatitis D historical perspective|Historical Perspective]]==


[[Image:Liver 1.jpg|thumbnail|center|400px|[[cirrhosis|Cirrhosis of the liver]] and [[hepatocellular carcinoma|liver cancer]] may ensue from Hepatitis D.]]
==[[Hepatitis D pathophysiology|Pathophysiology]]==


== The Delta Antigens ==
==[[Hepatitis D causes|Causes]]==


A significant difference between viroids and HDV is that, while viroids produce no proteins, HDV produces two proteins called the small and large delta antigens (HDAg-S and HDAg-L, respectively). These two proteins are produced from a single open reading frame. They are identical for 195 amino acids and differ only by the presence of an additional 19 amino acids at the C-terminus of HDAg-L. Despite having 90% identical sequences, these two proteins play diverging roles during the course of an infection. HDAg-S is produced in the early stages of an infection and is required for viral replication. HDAg-L, in contrast, is produced during the later stages of an infection, acts as an inhibitor of viral replication, and is required for assembly of viral particles.
==[[Hepatitis D differential diagnosis|Differentiating Hepatitis D from other Diseases]]==


== Risk Factors ==
==[[Hepatitis D epidemiology and demographics|Epidemiology and Demographics]]==
*Injection drug users
 
*Men who have sex with men
==[[Hepatitis D risk factors|Risk Factors]]==
*Hemodialysis patients
 
*Sex contacts of infected persons
==[[Hepatitis D screening|Screening]]==
Health care and public safety workers
 
Infants born to infected mothers (very rare) [http://www.cdc.gov/ncidod/diseases/hepatitis/d/fact.htm]
==[[Hepatitis D natural history|Natural History, Complications and Prognosis]]==
 
==Diagnosis==
[[Hepatitis D history and symptoms|History and Symptoms]] | [[Hepatitis D physical examination|Physical Examination]] | [[Hepatitis D laboratory findings|Laboratory Findings]] | [[Hepatitis D CT|CT]] | [[Hepatitis D MRI|MRI]] | [[Hepatitis D ultrasound|Ultrasound]] | [[Hepatitis D other diagnostic studies|Other Diagnostic Studies]]
 
==Treatment==
[[Hepatitis D medical therapy|Medical Therapy]] | [[Hepatitis D surgery|Surgery]] | [[Hepatitis D prevention|Prevention]] | [[Hepatitis D cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hepatitis D future or investigational therapies|Future or Investigational Therapies]]
 
==Related Chapters=
* [[Hepatitis A]]
* [[Hepatitis B]] 
* [[Hepatitis C]] 
* [[Hepatitis E]] 
* [[Hepatitis F]] 
* [[Hepatitis G]]


==External links==
==External links==
Line 37: Line 43:
<br>
<br>


{{SIB}}
{{viruses}}
{{viruses}}
{{WH}}
{{WS}}


[[Category:Hepatitis|D]]
[[Category:Hepatitis|D]]
[[Category:Viruses]]
[[Category:Viruses]]
 
[[Category:Mature chapter]]
[[de:Hepatitis D]]
[[Category:Disease]]
[[es:Hepatitis D]]
[[Category:Gastroenterology]]
[[it:Epatite virale D]]
[[Category:Emergency mdicine]]
[[ja:D型肝炎]]
[[Category:Up-To-Date]]
[[pl:Wirus zapalenia wątroby typu D]]
[[Category:Infectious disease]]
[[ru:Гепатит D]]
[[Category:Hepatology]]
[[zh:丁型肝炎]]
 
{{WH}}
{{WS}}

Latest revision as of 22:06, 29 July 2020

This page is about clinical aspects of the disease.  For microbiologic aspects of the causative organism(s), see Hepatitis D Virus.

For patient information click here

Hepatitis Main Page

Hepatitis D

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hepatitis D from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Hepatitis D On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis D

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis D

CDC on Hepatitis D

Hepatitis D in the news

Blogs on Hepatitis D

Directions to Hospitals Treating Hepatitis D

Risk calculators and risk factors for Hepatitis D

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]; João André Alves Silva, M.D. [3]; Jolanta Marszalek, M.D. [4]

Synonyms and keywords: Hepatitis delta virus; hepatitis D virus; HDV; Delta Hepatitis; HDV infection; Hep D; Hep d

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hepatitis D from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Ultrasound | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Related Chapters

External links


Template:Baltimore classification Template:Viral diseases

Template:WH Template:WS